4
Changes in Ownership
Enliven Therapeutics, Inc. Filed Acc 0001415889-24-002220
Director sold 1,270 shares at $16.41 ($20,840)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Heyman Richard A. · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-01-30 | Sale : show line 1 in the form 10b5-1 | −1,270 | $16.41 | $20,840 | 146,010 | D |
| Open-market sales · 1,270 sh · avg $16.41 · $20,840 | ||||||
Loading xslF345X05/form4-02022024_010213.xml…